|
AGREEMENT made as of the 26th day of October, 1977.
BETWEEN:
RESPERIN
CORPORATION LIMITED,
a
company incorporated under the laws
of
the Province of Ontario
(hereinafter
called "Resperin")
OF THE FIRST PART
-
and -
DAVID
FINGARD, of the Municipality
of
Metropolitan Toronto, in the Province
of
Ontario
(hereinafter
called "Mr. Fingard"
OF THE SECOND PART
-
and -
RENE
M. CAISSE, of the Town of
Bracebridge,
in the Province of Ontario,
Registered
Nurse
(hereinafter
called Rene M. Caisse)
OF THE THIRD PART
WHEREAS Rene M. Caisse represents and warrants to Resperin and
Mr. Fingard that she has developed and has sole and exclusive proprietary
rights to a treatment for the allevation and cure of cancer (such
treatment being hereinafter referred to as the "Essiac" treatment);
AND WHEREAS Rene M. Caisse also represents and warrants to Resperin
and Mr. Fingard that she has not disclosed to any other person or
company any particulars of the Essiac treatment or the formula for
or ingredients of any medication comprised therein;
AND WHEREAS Rene M. Caisse represents and warrants to Resperin
and Mr. Fingard that a sealed envelope containing all particulars
of the Essiac treatment and the formula for and ingredients of all
medication comprised therein has been lodged in trust agreement
(hereinafter called the "Trust Agreement") and that such Trust Agreement
provides, inter alia, that Rene M. Caisse may terminate the said
Trust Agreement and recover the said sealed envelope containing
all particulars of the Essiac treatment and the formula for and
ingredients of all medication comprised therein at any time;
AND WHEREAS Rene M. Caisse and Resperin have agreed to co-operate
in the promotion of the Essiac treatment for use throughout the
world in alleviation and cure of cancer all on and subject to the
terms of this agreement;
| 
